Stock market update: Nifty Pharma index falls 0.79% in an upbeat market

NEW DELHI:  The Nifty Pharma index traded negative around 10:19AM(IST)on Tuesday in an upbeat market.

Abbott India Ltd.(up 0.74 per cent), Gland Pharma Ltd.(up 0.68 per cent), Biocon Ltd.(up 0.41 per cent) and J B Chemicals & Pharmaceuticals Ltd.(up 0.03 per cent) were among the top gainers.

Dr. Reddy’s Laboratories Ltd.(down 3.1 per cent), Ipca Laboratories Ltd.(down 2.58 per cent), Aurobindo Pharma Ltd.(down 2.0 per cent), Ajanta Pharma Ltd.(down 1.87 per cent) and Granules India Ltd.(down 1.86 per cent) were the top losers on the index.

The Nifty Pharma index was down 0.79 per cent at 21599.05 at the time of writing this report.

Benchmark NSE Nifty50 index was up 147.66 points at 23806.0, while the BSE Sensex was up 552.08 points at 78536.46.

Among the 50 stocks in the Nifty index, 35 were trading in the green, while 15 were in the red.

Shares of Vodafone Idea, IREDA, YES Bank, Suzlon Energy and Ola Electric Mobilit were among the most traded shares on the NSE.

Shares of Cura Tech, Mahamaya Steel, Jupiter Life Line Hospitals, Bohra Industries and SBI Card hit their fresh 52-week highs in today’s trade, while Shrem InvIT, Sanco Industries, AGS Transact Tech, Marshall Machines and Praxis Home Retail hit fresh 52-week lows in trade.

Related Posts

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha has received investment commitments worth ₹7,043 crore across the pharmaceutical and medical technology sectors, marking a major step in strengthening the state’s position as an emerging healthcare manufacturing hub.…

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Mastermind of India’s massive codeine cough syrup racket skips ED summons- what’s next for Shubham Jaiswal? With arrest warrants, Red Corner Notices, and cross-border drug links, the investigation could expose…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16